Zhejiang Starry Pharmaceutical(603520.SH): Controlling shareholder intends to transfer 5.02% of the company's shares by agreement.

Zhejiang Starry Pharmaceutical (603520.SH) announced that in order to repay the stock pledge financing loan, the company's controlling shareholder and actual controller Hu Jian, Hu Jinsheng, and their concerted action person Shanghai Muxin Private Equity Fund Management Co., Ltd.- Muxin Chunchen No. 1 Private Equity Securities Investment Fund signed a "Share Transfer Agreement" with Ni Lianhui on September 12, 2024, intending to transfer 5.0181% of the company's shares held by them to Ni Lianhui through an agreement transfer method. The transfer price of the target shares is RMB 7.31 per share (including tax).